USING COMBINATORIAL THERAPIES WITH DENDRITIC CELL THERAPIES TO IMPROVE SURVIVAL AND PREVENT RECURRENCE OF BREAST CANCER LEPTOMENINGEAL DISEASE (LMD)
$2,481,041FY2025Defense Health AgencyDOD
Kent State University, Kent OH
Kent State University, Kent OH